Bharucha AE, Charkoudian N, Andrews CN, Camilleri M, Sletten D, Zinsmeister AR, Low PA
Guidelines and Recommendations : Professional organizations, such as the American Diabetes Association (ADA) and the Endocrine Society, periodically release guidelines that include considerations for the use of GLP-1 receptor agonists like semaglutide, taking into account their impact on gallbladder health among other safety and efficacy factors
However, there are several concerns about the SUMMIT trial that need to be clarified
Understanding who may benefit from this medicine is important so patients and doctors can make the best decisions together
It was first created for adults with type 2 diabetes, but many people have noticed weight loss as a side effect